Ethnic differences in drug metabolism and toxicity from chemotherapy
Viet Hong Phan(Concord Repatriation General Hospital), Stephen Clarke(The University of Sydney), Micheline Piquette‐Miller(University of Toronto), Melissa M. Moore(St. Vincent's Birmingham), Andrew J. McLachlan(The University of Sydney), Hongmei Xu(First Hospital of Qinhuangdao)
Cited by 122
Related Papers
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
|Journal of Clinical Epidemiology|2012|1.2k
Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis
|BMJ Open|2016|527
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
|The Lancet Oncology|2012|526
Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies
|Thrombosis and Haemostasis|2014|467